Om Fresenius Kabi

Fresenius Kabi at a glance

Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. In the field of biosimilars, we focus on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporal therapies.

About us

KLIK HER FOR MERE INFORMATION OM:

Alle ovennævnte links er til fresenius-kabi.com, og al information er på engelsk